Ab initio molecular simulations based on FMO method for proposing potent inhibitors to reverse transcriptase of HIV

被引:0
作者
Takeda, Ryosuke [1 ]
Kadoya, Ryushi [1 ]
Kobayashi, Ittetsu [1 ]
Kurita, Noriyuki [1 ]
Kamsri, Pharit [2 ]
Meewong, Pijittra [2 ]
Pungpo, Pornpan [2 ]
机构
[1] Toyohashi Univ Technol, Dept Comp Sci & Engn, Tempaku Cho, Toyohashi, Aichi 4418580, Japan
[2] Ubon Ratchathani Univ, Fac Sci, Dept Chem, 85 Sthollmark Rd, Warinchamrap 34190, Ubonratchathani, Thailand
来源
2016 INTERNATIONAL CONFERENCE ON ADVANCED INFORMATICS - CONCEPTS, THEORY AND APPLICATION (ICAICTA) | 2016年
关键词
Fragment molecular orbital; drug design; specific interaction; protein; ligand; WILD-TYPE; DIARYLPYRIMIDINES; DESIGN;
D O I
暂无
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
The reverse transcriptase (RT) existing in HIV has been recognized to play an essential role for increasing HIV. It is thus expected that inhibition of the RT activity prevents the increase of HIV. Many types of diarylpyrimidines were synthesized as the inhibitors to RT. Among them, TMC125 and TMC278 were found to play important roles in inhibiting RT activity. In the present study, we picked up some TMC278 derivatives as ligands and investigated the specific interactions between RT and the ligands at atomic and electronic levels, using ab initio fragment molecular orbital (FMO) calculations. First, the derivatives were docked into the ligand-binding pocket of RT using a protein-ligand docking program, and the docked structures were fully optimized in water by a classical molecular mechanics method. Finally, using ab initio FMO calculations, the specific interactions between each amino acid residue of RT and the derivatives were revealed at an electronic level. Based on the FMO results, we proposed some novel inhibitors to RT and demonstrated that one of them binds strongly to RT.
引用
收藏
页数:6
相关论文
共 22 条
[1]  
[Anonymous], P PUR APPL CHEM INT
[2]  
[Anonymous], ANSCSE19 UB RATCH U
[3]  
[Anonymous], CURR OPIN STRUCT BIO
[4]  
Case D., 2014, AMBER, V14
[5]   Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants [J].
Das, K ;
Clark, AD ;
Lewi, PJ ;
Heeres, J ;
de Jonge, MR ;
Koymans, LMH ;
Vinkers, HM ;
Daeyaert, F ;
Ludovici, DW ;
Kukla, MJ ;
De Corte, B ;
Kavash, RW ;
Ho, CY ;
Ye, H ;
Lichtenstein, MA ;
Andries, K ;
Pauwels, R ;
de Béthune, MP ;
Boyer, PL ;
Clark, P ;
Hughes, SH ;
Janssen, PAJ ;
Arnold, E .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) :2550-2560
[6]   High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: Strategic flexibility explains potency against resistance mutations [J].
Das, Kalyan ;
Bauman, Joseph D. ;
Clark, Arthur D., Jr. ;
Frenkel, Yulia V. ;
Lewi, Paul J. ;
Shatkin, Aaron J. ;
Hughes, Stephen H. ;
Arnold, Eddy .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (05) :1466-1471
[7]  
Frisch M., 2010, Wallingford, CT
[8]   Intra- and intermolecular interactions between cyclic-AMP receptor protein and DNA:: Ab initio fragment molecular orbital study [J].
Fukuzawa, K ;
Komeiji, Y ;
Mochizuki, Y ;
Kato, A ;
Nakano, T ;
Tanaka, S .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2006, 27 (08) :948-960
[9]   Etravirine [J].
Haubrich, Richard ;
Gubernick, Steven ;
Yasothan, Uma ;
Kirkpatrick, Peter .
NATURE REVIEWS DRUG DISCOVERY, 2008, 7 (04) :287-288
[10]   COMPARISON OF SIMPLE POTENTIAL FUNCTIONS FOR SIMULATING LIQUID WATER [J].
JORGENSEN, WL ;
CHANDRASEKHAR, J ;
MADURA, JD ;
IMPEY, RW ;
KLEIN, ML .
JOURNAL OF CHEMICAL PHYSICS, 1983, 79 (02) :926-935